EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark APMYZEP was filed as Word mark on 09/18/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/19/2021.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018309757 |
| Application date | September 18, 2020 |
| Publication date | December 10, 2020 |
| Entry date | March 19, 2021 |
| Expiration date | September 18, 2030 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations namely, pharmaceutical preparations for the prevention, diagnosis and/or treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, and cluster headaches; Pharmaceutical preparations for the prevention, diagnosis and/or treatment of Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, pharmaceutical preparations for the prevention, diagnosis and/or treatment of gastrointestinal diseases and disorders, headaches, heart failure, and hypoglycaemia; Pharmaceutical preparations for the prevention, diagnosis and/or treatment of inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders; Pharmaceutical preparations for the prevention, diagnosis and/or treatment of neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, and ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain; pharmaceutical preparations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 24, 2020 | Change Representative, Registered |
ID: 11018309757